Amanda Kulick

3.0k total citations · 1 hit paper
13 papers, 1.6k citations indexed

About

Amanda Kulick is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Amanda Kulick has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Amanda Kulick's work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Amanda Kulick is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Amanda Kulick collaborates with scholars based in United States, Germany and Spain. Amanda Kulick's co-authors include Scott W. Lowe, Josef Leibold, Yu-Jui Ho, Judith Feucht, Direna Alonso‐Curbelo, Elisa de Stanchina, Theodoros Giavridis, Jacob A. Boyer, Vladimir Ponomarev and Corina Amor and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Amanda Kulick

13 papers receiving 1.6k citations

Hit Papers

Senolytic CAR T cells reverse senescence-associated patho... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Kulick United States 9 640 527 518 491 215 13 1.6k
Josef Leibold United States 9 833 1.3× 539 1.0× 819 1.6× 671 1.4× 177 0.8× 13 2.0k
Direna Alonso‐Curbelo United States 14 947 1.5× 594 1.1× 540 1.0× 595 1.2× 112 0.5× 20 1.9k
Janelle Simon United States 11 993 1.6× 457 0.9× 727 1.4× 504 1.0× 132 0.6× 13 2.0k
Ilaria Guccini Switzerland 12 468 0.7× 306 0.6× 315 0.6× 371 0.8× 145 0.7× 15 1000
Sandra Pinton Switzerland 15 685 1.1× 282 0.5× 405 0.8× 407 0.8× 232 1.1× 24 1.3k
М. М. Попов Ukraine 4 893 1.4× 764 1.4× 299 0.6× 510 1.0× 89 0.4× 14 1.7k
Cornelia Rudolph Germany 18 1.4k 2.2× 667 1.3× 523 1.0× 287 0.6× 72 0.3× 41 2.1k
Ayako Nakamura‐Ishizu Japan 21 1.0k 1.6× 201 0.4× 183 0.4× 538 1.1× 130 0.6× 43 2.1k
Manuela Sarti Italy 16 893 1.4× 248 0.5× 537 1.0× 417 0.8× 434 2.0× 28 1.7k
Shauna L Houlihan United States 5 392 0.6× 330 0.6× 189 0.4× 248 0.5× 44 0.2× 6 910

Countries citing papers authored by Amanda Kulick

Since Specialization
Citations

This map shows the geographic impact of Amanda Kulick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Kulick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Kulick more than expected).

Fields of papers citing papers by Amanda Kulick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Kulick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Kulick. The network helps show where Amanda Kulick may publish in the future.

Co-authorship network of co-authors of Amanda Kulick

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Kulick. A scholar is included among the top collaborators of Amanda Kulick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Kulick. Amanda Kulick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mezzadra, Riccardo, Almudena Chaves Perez, Amanda Kulick, et al.. (2025). A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma. Cancer Discovery. 15(8). 1717–1739. 2 indexed citations
2.
Pratt, Edwin C., Riccardo Mezzadra, Amanda Kulick, et al.. (2024). uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence. Journal of Nuclear Medicine. 65(11). 1718–1723. 1 indexed citations
3.
Dorso, M., Payal T. Patel, Aleksandr Pankov, et al.. (2023). A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer. Cancer Research Communications. 3(9). 1788–1799. 2 indexed citations
4.
Paffenholz, Stella, Camilla Salvagno, Yu-Jui Ho, et al.. (2022). Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer. Proceedings of the National Academy of Sciences. 119(5). 50 indexed citations
5.
Smith, Alison, Emanuela Ferraro, Anton Safonov, et al.. (2021). HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway. Nature Communications. 12(1). 6667–6667. 61 indexed citations
6.
Amor, Corina, Judith Feucht, Josef Leibold, et al.. (2020). Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 583(7814). 127–132. 724 indexed citations breakdown →
7.
Ruscetti, Marcus, John P. Morris, Riccardo Mezzadra, et al.. (2020). Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 181(2). 424–441.e21. 281 indexed citations
8.
Russell, James, Milan Grkovski, Teja Kalidindi, et al.. (2020). Predicting Gemcitabine Delivery by18F-FAC PET in Murine Models of Pancreatic Cancer. Journal of Nuclear Medicine. 62(2). 195–200. 7 indexed citations
9.
Ruscetti, Marcus, Josef Leibold, Matthew J. Bott, et al.. (2018). NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 362(6421). 1416–1422. 268 indexed citations
10.
Mattar, Marissa S., et al.. (2018). Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models. Frontiers in Oncology. 8. 19–19. 35 indexed citations
11.
Ichihara, Eiki, David Westover, Catherine B. Meador, et al.. (2017). SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer. Cancer Research. 77(11). 2990–3000. 104 indexed citations
12.
Wong, Karen, Amanda Kulick, Elisa de Stanchina, et al.. (2017). CryoPause: A New Method to Immediately Initiate Experiments after Cryopreservation of Pluripotent Stem Cells. Stem Cell Reports. 9(1). 355–365. 17 indexed citations
13.
Williams, Ryan M., et al.. (2014). In VitroSelection of a Single-Stranded DNA Molecular Recognition Element Specific for Bromacil. Journal of Nucleic Acids. 2014. 1–8. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026